Takumi Takeuchi

Dr. Takumi Takeuchi

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2018 in Canadian Urological Association Journal
Verified
Journal Article
Open access
PDF file
TTTakumi Takeuchi
Takumi Takeuchi
MHMami Hattori-Kato
Mami Hattori-Kato
YOYumiko Okuno
Yumiko Okuno
SISatoshi Iwai
Satoshi Iwai
KMKoji Mikami
Koji Mikami
Introduction: To predict the rate of prostate cancer detection on prostate biopsy more accurately, the performance of deep learning using a multilayer artificial neural network was investigated. Methods: A total of 334 patients who underwent multiparametric magnetic resonance imaging before ultrasonography guided transrectal 12-core prostate biopsy were enrolled in the analysis. Twenty-two non-selected variables, as well as selected ones by least absolute shrinkage and selection operator (Lasso) regression analysis and by stepwise logistic regression analysis, were input into the constructed multilayer artificial neural network (ANN) programs; 232 patients were used as training cases of ANN programs and the remaining 102 patients were for the test to output the probability of prostate cancer existence, accuracy of prostate cancer prediction, and area under the receiver operating characteristic (ROC) curve with the learned model. Results: With any prostate cancer objective variable, Lasso and stepwise regression analyses selected 12 and nine explanatory variables, respectively, from 22. Using trained ANNs with multiple hidden layers, the accuracy of predicting any prostate cancer in test samples was about 5–10% higher compared to that with logistic regression analysis (LR). The area under the curves (AUC) with multilayer ANN were significantly larger on inputting variables that were selected by the stepwise LR compared with the AUC with LR. The ANN had a higher net benefit than LR between prostate cancer probability cutoff values of 0.38 and 0.6. Conclusions: ANN accurately predicted prostate cancer without biopsy marginally better than LR. However, for clinical application, ANN performance may still need improvement.

20 October 2011 in Advances in Urology
Verified
Journal Article
Open access
PDF file
MZMasayoshi Zaitsu
Masayoshi Zaitsu
Koji MikamiKoji Mikami
Koji Mikami
NINoriko Ishida
Noriko Ishida
TTTakumi Takeuchi
Takumi Takeuchi
Objectives. Overactive bladder (OAB) is a chronic disease, but comparative trials of anticholinergics, which are commonly used for treatment of OAB, have generally been performed for up to 12 weeks only. There is no comparative study of a long-term intervention.Methods. We conducted a 52-week prospective randomized comparative study to evaluate the efficacy and tolerability of two anticholinergics.Results. Forty-one Japanese patients with untreated OAB were randomly assigned to imidafenacin and solifenacin groups. There was no difference in OABSS and KHQ scores between the two groups, but the severity and incidence of adverse events caused by the anticholinergics showed increased differences between the groups with time. The severity of dry mouth and the incidence of constipation were significantly lower in the imidafenacin group ( and , resp.).Conclusions. This study is the first long-term trial to show differences in the properties of anticholinergics that were not detected in short-term studies. Since OAB is a chronic disease, we conclude that imidafenacin is preferable to solifenacin from a perspective of safety.

1 January 2016 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
TTTakumi Takeuchi
Takumi Takeuchi
YOYumiko Okuno
Yumiko Okuno
MZMasayoshi Zaitsu
Masayoshi Zaitsu
MHMami Hattori-Kato
Mami Hattori-Kato
KMKoji Mikami
Koji Mikami
A splice variant of androgen receptor (AR), AR-V7, lacks in androgen-binding portion and leads to aggressive cancer characteristics. Reverse transcription-polymerase chain reactions (PCRs) and subsequent nested PCRs for the amplification of AR-V7 and prostate-specific antigen (PSA) transcripts were done for whole blood of patients with prostate cancer and male controls. With primary reverse transcription PCRs, AR-V7 and PSA were detected in 4.5% and 4.7% of prostate cancer, respectively. With nested PCRs, AR-V7 messenger RNA (mRNA) was positive in 43.8% of castration-sensitive prostate cancer and 48.1% of castration-resistant prostate cancer (CRPC), while PSA mRNA was positive in 6.3% of castration-sensitive prostate cancer and 18.5% of CRPC. Whole-blood samples of controls showed AR-V7 mRNA expression by nested PCR. Based on multivariate analysis, expression of AR-V7 mRNA in whole blood was not significantly correlated with clinical parameters and PSA mRNA in blood, while univariate analysis showed a correlation between AR-V7 mRNA and metastasis at initial diagnosis. Detection of AR-V7 mRNA did not predict the reduction of serum PSA in patients with CRPC following abiraterone and enzalutamide administration. In conclusion, AR-V7 mRNA expression in normal hematopoietic cells may have annihilated the manifestation of aggressiveness of prostate cancer and the prediction of the effectiveness of abiraterone and enzalutamide by the assessment of AR-V7 mRNA in blood.

1 January 2016 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
MZMasayoshi Zaitsu
Masayoshi Zaitsu
FNFumiaki Nakamura
Fumiaki Nakamura
STSatoshi Toyokawa
Satoshi Toyokawa
ATAkiko Tonooka
Akiko Tonooka
TTTakumi Takeuchi
Takumi Takeuchi
YKYasuki Kobayashi
Yasuki Kobayashi
Bladder cancer is common in Western countries, but not in Japan. Established risk factors are smoking and high-risk jobs such as printing and manufacturing. The risk of alcohol consumption in bladder cancer has been the recent focus; however, available literature on alcohol consumption and bladder cancer has been limited from Japanese population, thought to have a weak genetic tolerance to acetaldehyde. We aimed to determine whether alcohol consumption is an independent risk factor for bladder cancer among Japanese. The study was a matched case-control study from the nationwide Japanese clinical database administered by the Rosai Hospital group. We identified 739 cases of bladder cancer diagnosed between 2005 (when the database was established) and 2014 and 7,196 controls matched by sex, age, hospital, and admission period. We estimated the odds ratio of alcohol consumption for bladder cancer adjusted for the amount of smoking, high-risk occupations, and comorbidities (hypertension, hyperlipidemia, diabetes, hyperuricemia, and obesity) with conditional logistic regression. The risk of bladder cancer was significantly higher in ever drinkers than in never drinkers (odds ratio, 1.33; 95% confidence interval, 1.06 to 1.66). Furthermore, the risk threshold for alcohol consumption was more than 15 g of alcohol intake per day (one, 180-mL cup equivalent to 6 ounces of Japanese sake containing 23 grams of alcohol). Among Japanese, alcohol consumption may be an independent risk factor for bladder cancer, with a lower risk threshold.

1 June 2017 in Cancer Epidemiology
Verified
Journal Article
Closed access
MZMasayoshi Zaitsu
Masayoshi Zaitsu
IKIchiro Kawachi
Ichiro Kawachi
TTTakumi Takeuchi
Takumi Takeuchi
YKYasuki Kobayashi
Yasuki Kobayashi

29 September 2007 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
YYYuta Yamada
Yuta Yamada
STSatoru Takahashi
Satoru Takahashi
TFT. Fujimura
T. Fujimura
HNH. Nishimatsu
H. Nishimatsu
AIA. Ishikawa
A. Ishikawa
TKT. Kitamura
T. Kitamura